Aileron raises $56.3M in IPO

On June 28, oncology play Aileron Therapeutics Inc. (NASDAQ:ALRN) raised $56.3 million through the sale of 3.8 million shares at $15 in an IPO underwritten by BofA Merrill Lynch, Jefferies, William B...